Skip to search formSkip to main contentSkip to account menu

MLR-1023

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
Review
2017
2012
2012
2(1H)-pyrimidinone,5-(3-methylphenoxy) (MLR-1023) is a candidate for the treatment of type 2 diabetes. The current studies were… 
2012
2012
MLR-1023 [Tolimidone; CP-26154; 2(1H)-pyrimidinone, 5-(3-methylphenoxy)] is an allosteric Lyn kinase activator that reduces blood…